Endocrine and Diabetes Biomarkers

A biomarker is any substance, structure, or process that should be measurable in the body or its products and it also influences or predicts the incidence of outcome or disease. For predicting type 1 diabetes, a biomarker should be present in a subset of the population, and this subset should have an influence on the proportion of people in whom this type 1 diabetes develops. A biomarker should also present a significant risk for the development of type 1 diabetes within a defined period of time or diagnose a “stage” in the progression to clinical or symptomatic type1 diabetes. As described in this article, most of the biomarkers are  used for the prediction of type 1 diabetes are islet-specific supporting the concept that, before overt hyperglycaemia, type 1 diabetes is generally predominantly a targeted disease rather than a systemic disease.

Atomic Biomarkers can be separated as a trademark that is precisely measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.

Biomarkers have fundamental influences in driving clinical trials and treating the patients. Progress in sub-atomic diagnostics helps medicinal experts make proficient, experimentally legitimate choices. All the more efficient disclosure and use of biomarkers in the development of ant diabetes medications will rely on upon quickening our comprehension of the pathogenesis of diabetes and particularly its macro vascular entanglements. Procedural upgrades in different fields, particularly tumour, are started to demonstrate the way towards the better models of diabetes pathogenesis and atomic biomarker revelation.

 

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular marker for metabolic syndrome
  • Molecular Marker-Hypoglycaemic response
  • Inflammatory markers: Type 2 diabetes

Related Conference of Endocrine and Diabetes Biomarkers

November 28-29, 2022

International Conference on Diabetes & Heart Diseases

Yokohama, Japan
November 28-29, 2022

14th World Congress on Endocrinology and Metabolic Disorders

Amsterdam, Netherlands
January 30-31, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
February 22-23, 2023

32nd European Diabetes Congress

Madrid, Spain
March 27-28, 2023

56th Annual Congress on Endocrinology & Disorders

Vancouver, Canada
April 18-19, 2023

Global Summit on Endocrinology

Madrid, Spain
April 18-19, 2023

European Endocrinology and Diabetes Congress

Madrid, Spain
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain
June 05-06, 2023

World Congress on Endocrine and Diabetes

San Francisco, USA
June 15-16, 2023

4th Annual conference on Diabetes

San Francisco, USA
July 24-25, 2023

19th International Conference on Diabetes & Care

Venice, Italy
August 10-11, 2023

25th World Congress on Diabetes and Endocrine Disorders

Dublin, Ireland
September 12-13, 2023

7th Annual Conference on Diabetes and Endocrinology

Barcelona, Spain
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA

Endocrine and Diabetes Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in